Literature DB >> 656114

Effects of 1,1'-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman- and sarin-inhibited cholinesterase by oximes.

L W Harris, W C Heyl, D L Stitcher, C A Broomfield.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 656114     DOI： 10.1016/0006-2952(78)90516-6

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN： 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  6 in total

1.  Potentiation effect of choline esters on choline-catalysed decarbamoylation of dimethylcarbamoyl-acetylcholinesterase.

Authors:  Y B Kim; C H Jung; S J Choi; W J Seo; S H Cha; D E Sok
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

2.  In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human.

Authors:  J G Clement; N Erhardt
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

3.  Methantheline improves the reactivation by HI 6 of human erythrocyte acetylcholinesterase inhibited by soman in vitro.

Authors:  M Hallek; L Szinicz
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

4.  Multiple binding sites involved in the effect of choline esters on decarbamoylation of monomethylcarbamoyl- or dimethylcarbamoly-acetylcholinesterase.

Authors:  D E Sok; Y B Kim; S J Choi; C H Jung; S H Cha
Journal:  Biochem J       Date:  1994-08-01       Impact factor: 3.857

5.  Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2.

Authors:  Z Grubic; A Tomazic
Journal:  Arch Toxicol       Date:  1989       Impact factor: 5.153

6.  Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings.

Authors:  Kamil Kuca; Jana Zdarova Karasova; Ondrej Soukup; Jiri Kassa; Eva Novotna; Vendula Sepsova; Anna Horova; Jaroslav Pejchal; Martina Hrabinova; Eva Vodakova; Daniel Jun; Eugenie Nepovimova; Martin Valis; Kamil Musilek
Journal:  Drug Des Devel Ther       Date:  2018-03-09       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.